Tomonari Abe, President of Abe Yoando Pharma, Selected as First Japanese Speaker at Longevity Investors Conference 2026 in Switzerland

ConferencePositive

AI Analysis

Summary

Tomonari Abe, President of Abe Yoando Pharma, has been selected as the first Japanese speaker at the Longevity Investors Conference 2026 in Switzerland to present Asia's longevity growth strategies and bioscientific research initiatives.

Importance:2/10

Sentiment:

0.30

conferencelongevityAsiaJapanbusiness_development

Related Companies

$XAGEW $TRAX

Read the original article

Published by PR Newswire Clinical Trials on September 14, 2026 6:00 AM

Read Original